Ati cautat: boli renale
OMS recomanda al doilea rapel anti-Covid pentru pacientii vulnerabili si personalul sanitar
Protocol terapeutic: A16AX09 – GLYCEROLI PHENYLBUTYRAS (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: R07AX02 – DCI IVACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AX04 – DCI LENALIDOMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE26 – DCI CABOZANTINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC28 – DCI DURVALUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC11-17 – DCI NIVOLUMAB + DCI IPILIMUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J02AC05 – DCI ISAVUCONAZOLUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: C10BX13 – COMBINAĊ˘II (ROSUVASTATINUM + PERINDOPRILUM + INDAPAMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB15 – DCI VELMANAZA ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
